|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2007-7-25
|
|
pubmed:abstractText |
Preliminary data on the use of autologous stem cell transplantation (ASCT) as a salvage therapy for peripheral T-cell lymphoma (PTCL) indicate that the results are similar to those obtained in aggressive B-cell lymphomas. The aim of our study was to analyze outcomes of a large series of patients with PTCL with a prolonged follow-up who received ASCT as salvage therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1592-8721
|
|
pubmed:author |
pubmed-author:ArranzReyesR,
pubmed-author:BendandiMaurizioM,
pubmed-author:CaballeroMaría DoloresMD,
pubmed-author:CondeEulogioE,
pubmed-author:Fernández de SevillaAlbertoA,
pubmed-author:Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea, Spanish...,
pubmed-author:GutiérrezAntonioA,
pubmed-author:LahuertaJuan JoséJJ,
pubmed-author:LeónAngelA,
pubmed-author:RodríguezJoséJ,
pubmed-author:SolanoCarlosC,
pubmed-author:SuredaAnnaA,
pubmed-author:VarelaMaría RosarioMR,
pubmed-author:ZuazuJavierJ
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
92
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1067-74
|
|
pubmed:meshHeading |
pubmed-meshheading:17640855-Adult,
pubmed-meshheading:17640855-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17640855-Bone Marrow Transplantation,
pubmed-meshheading:17640855-Combined Modality Therapy,
pubmed-meshheading:17640855-Disease-Free Survival,
pubmed-meshheading:17640855-Drug Resistance, Neoplasm,
pubmed-meshheading:17640855-Female,
pubmed-meshheading:17640855-Follow-Up Studies,
pubmed-meshheading:17640855-Humans,
pubmed-meshheading:17640855-Lymphoma, T-Cell, Peripheral,
pubmed-meshheading:17640855-Male,
pubmed-meshheading:17640855-Middle Aged,
pubmed-meshheading:17640855-Peripheral Blood Stem Cell Transplantation,
pubmed-meshheading:17640855-Prognosis,
pubmed-meshheading:17640855-Recurrence,
pubmed-meshheading:17640855-Remission Induction,
pubmed-meshheading:17640855-Salvage Therapy,
pubmed-meshheading:17640855-Severity of Illness Index,
pubmed-meshheading:17640855-Survival Analysis,
pubmed-meshheading:17640855-Survival Rate,
pubmed-meshheading:17640855-Transplantation, Autologous,
pubmed-meshheading:17640855-Treatment Outcome,
pubmed-meshheading:17640855-Tumor Markers, Biological,
pubmed-meshheading:17640855-beta 2-Microglobulin
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
The adjusted International Prognostic Index and beta-2-microglobulin predict the outcome after autologous stem cell transplantation in relapsing/refractory peripheral T-cell lymphoma.
|
|
pubmed:affiliation |
Oncology Department, University Hospital Son Dureta, Palma de Mallorca, Balearic Islands, Spain. jrodriguez@hsd.es
|
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|
